| GC33537-1mg |
|
118525-36-3 |
|
0 |
C32H38O14 |
|
|
|
| GC33537-10mg |
|
118525-36-3 |
|
0 |
C32H38O14 |
|
|
|
| GC33536-10mg |
|
1142095-93-9 |
Etravirine D4 (TMC-125 D4)
|
0 |
C20H11D4BrN6O |
|
|
|
| GC33536-5mg |
|
1142095-93-9 |
Etravirine D4 (TMC-125 D4)
|
0 |
C20H11D4BrN6O |
|
|
|
| GC33536-1mg |
|
1142095-93-9 |
Etravirine D4 (TMC-125 D4)
|
0 |
C20H11D4BrN6O |
|
|
|
| GC33535-5g |
|
131-53-3 |
Dioxybenzone (Benzophenone-8)
|
0 |
C14H12O4 |
|
|
|
| GC33535-10mM(1mLinDMSO) |
|
131-53-3 |
Dioxybenzone (Benzophenone-8)
|
0 |
C14H12O4 |
|
|
|
| GC33534-1g |
|
2237-36-7 |
2-Hydroxy-4-methoxybenzoic acid
|
0 |
C8H8O4 |
|
|
|
| GC33533-100mg |
|
816432-15-2 |
|
0 |
C18H27N3O6 |
|
|
|
| GC33533-50mg |
|
816432-15-2 |
|
0 |
C18H27N3O6 |
|
|
|
| GC33533-10mg |
|
816432-15-2 |
|
0 |
C18H27N3O6 |
|
|
|
| GC33533-5mg |
|
816432-15-2 |
|
0 |
C18H27N3O6 |
|
|
|
| GC33533-2mg |
|
816432-15-2 |
|
0 |
C18H27N3O6 |
|
|
|
| GC33532-50mg |
|
53016-31-2 |
Norgestimate metabolite Norelgestromin (17-Deacetyl norgestimate)
|
0 |
C21H29NO2 |
|
|
|
| GC33532-10mg |
|
53016-31-2 |
Norgestimate metabolite Norelgestromin (17-Deacetyl norgestimate)
|
0 |
C21H29NO2 |
|
|
|
| GC33532-5mg |
|
53016-31-2 |
Norgestimate metabolite Norelgestromin (17-Deacetyl norgestimate)
|
0 |
C21H29NO2 |
|
|
|
| GC33532-10mM(1mLinDMSO) |
|
53016-31-2 |
Norgestimate metabolite Norelgestromin (17-Deacetyl norgestimate)
|
0 |
C21H29NO2 |
|
|
|
| GC33531-50mg |
|
1691249-44-1 |
(R)-Zanubrutinib ((R)-BGB-3111)
|
0 |
C27H29N5O3 |
|
|
|
| GC33531-10mg |
|
1691249-44-1 |
(R)-Zanubrutinib ((R)-BGB-3111)
|
0 |
C27H29N5O3 |
|
|
|
| GC33531-5mg |
|
1691249-44-1 |
(R)-Zanubrutinib ((R)-BGB-3111)
|
0 |
C27H29N5O3 |
|
|
|
